ATE354351T1 - Alginatgele mit verzögerter freisetzung - Google Patents

Alginatgele mit verzögerter freisetzung

Info

Publication number
ATE354351T1
ATE354351T1 AT98915592T AT98915592T ATE354351T1 AT E354351 T1 ATE354351 T1 AT E354351T1 AT 98915592 T AT98915592 T AT 98915592T AT 98915592 T AT98915592 T AT 98915592T AT E354351 T1 ATE354351 T1 AT E354351T1
Authority
AT
Austria
Prior art keywords
alginat
gels
delayed release
sustained
methods
Prior art date
Application number
AT98915592T
Other languages
English (en)
Inventor
Merrill Seymour Goldenberg
Alice C Beekman
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE354351T1 publication Critical patent/ATE354351T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
AT98915592T 1997-04-17 1998-04-14 Alginatgele mit verzögerter freisetzung ATE354351T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/842,756 US6656508B2 (en) 1997-04-17 1997-04-17 Sustained-release alginate gels

Publications (1)

Publication Number Publication Date
ATE354351T1 true ATE354351T1 (de) 2007-03-15

Family

ID=25288180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98915592T ATE354351T1 (de) 1997-04-17 1998-04-14 Alginatgele mit verzögerter freisetzung

Country Status (13)

Country Link
US (1) US6656508B2 (de)
EP (1) EP0975333B1 (de)
JP (1) JP2001524084A (de)
AT (1) ATE354351T1 (de)
AU (1) AU6973498A (de)
CA (1) CA2286092C (de)
DE (1) DE69837140T2 (de)
DK (1) DK0975333T3 (de)
ES (1) ES2283052T3 (de)
PT (1) PT975333E (de)
TW (1) TW577755B (de)
WO (1) WO1998046211A1 (de)
ZA (1) ZA983089B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
ES2253851T3 (es) 1998-08-07 2006-06-01 Curis, Inc. Composicion farmaceutica estable de proteinas hedgehog y uso de la misma.
HUP0104126A3 (en) * 1998-10-28 2004-07-28 Sankyo Company Ltd Chuo Ku Remedies for bone metabolic errors
KR100845769B1 (ko) * 1999-02-03 2008-07-11 파우더젝트 리서치 리미티드 하이드로겔 입자 제제
EP1158961A1 (de) * 1999-03-08 2001-12-05 PowderJect Research Limited Verabreichung von mikroteilchen-formulierungen unter verwendung einer nadellosen spritze zur verzörgerten freigabe bioaktiver verbindungen
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
EP1537860A1 (de) * 2000-05-12 2005-06-08 Pharmacia & Upjohn Company LLC Impfstoffzusammensetzung und Verfahren zur Herstellung derselben sowie Verfahren zur Impfung von Wirbeltieren
ES2243497T3 (es) * 2000-05-12 2005-12-01 PHARMACIA & UPJOHN COMPANY LLC Composicion de vacuna, procedimiento de preparacion de la misma y procedimiento para vacunacion de vertebrados.
US20030022856A1 (en) * 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
EP1270015A3 (de) * 2001-06-29 2004-02-25 Sankyo Company Limited Ein Komplex enthaltend OCIF und einem Polysaccharid
JP2003081865A (ja) * 2001-09-12 2003-03-19 Ltt Institute Co Ltd 水不溶性徐放性組成物、その製剤及びその製造方法
US20040005999A1 (en) * 2002-03-07 2004-01-08 Andreasen Kasper Huus Polyamino acid-based particle insulin preparation
US6840196B2 (en) 2002-03-13 2005-01-11 Aspen Pet Products, Inc. Rawhide pet chew
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US8112400B2 (en) * 2003-12-23 2012-02-07 Texas Instruments Incorporated Method for collecting data from semiconductor equipment
FI116625B (fi) * 2004-01-28 2006-01-13 Macrocrystal Oy Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
EP1781282A4 (de) * 2004-07-23 2010-09-01 Dpi Solutions Inc Zusammensetzung zur stabilisierung von vitamin c in wasserphase und diese verwendendes verfahren zur stabilisierung von vitamin c
CA2583308C (en) * 2004-10-08 2020-01-07 Georgia Tech Research Corporation Microencapsulation of cells in hydrogels using electrostatic potentials
EP1799232B1 (de) 2004-10-12 2015-10-07 FMC Biopolymer AS Selbstgelierende alginatsysteme und verwendungsmöglichkeiten dafür
US20060099550A1 (en) * 2004-11-10 2006-05-11 Ranir/Dcp Corporation Device and method for delivering an oral care agent
CA2615173C (en) 2005-07-14 2012-01-03 Lipothera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
TWI285100B (en) * 2005-12-27 2007-08-11 Ind Tech Res Inst Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
WO2007146319A2 (en) * 2006-06-13 2007-12-21 Symphony Medical, Inc. Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
GB0624227D0 (en) * 2006-12-05 2007-01-10 Common Services Agency Protein purification
JP5162134B2 (ja) * 2007-01-22 2013-03-13 愛媛県 機能性材料の製造方法、機能性材料、シート状構造体、及び衛生製品
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
CN103463638A (zh) * 2007-08-28 2013-12-25 Fmc有限公司 延迟的自胶凝藻酸盐体系及其应用
EP2207568B1 (de) 2007-11-16 2017-05-31 The Rockefeller University Für die protofibrillenform des proteins beta-amyloid spezifische antikörper
CN102438657A (zh) * 2009-03-26 2012-05-02 沃萨乌整形外科公司 鉴别定向药物递送组合物的潜在组分的方法
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2487868B (en) * 2010-01-15 2014-12-10 Neothetics Inc Lyophilized cake formulations
EP2590605A1 (de) 2010-07-09 2013-05-15 Board of Regents of the University of Texas System Biologisch abbaubare gerüste
UA111822C2 (uk) 2010-11-24 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Новамедіка" Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання
GB201120368D0 (en) 2011-11-24 2012-01-04 Sperm Vital As Methods for the preparation of hydrogels
CN103830266A (zh) * 2013-04-24 2014-06-04 杨亚勤 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用
US10383825B2 (en) 2015-08-13 2019-08-20 Temple University—Of the Commonwealth System of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
US10729771B2 (en) 2016-02-10 2020-08-04 Rutgers, The State University Of New Jersey Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections
WO2017179611A1 (ja) 2016-04-13 2017-10-19 株式会社Ｌｓｉメディエンス 硫酸化多糖類を用いた免疫学的測定法
US10981976B2 (en) 2016-08-31 2021-04-20 University Of Rochester Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
WO2020045162A1 (ja) * 2018-08-30 2020-03-05 学校法人慶應義塾 薬物送達用担体
JP7768735B2 (ja) * 2021-11-16 2025-11-12 新田ゼラチン株式会社 生体吸収性粒子
WO2025212191A1 (en) * 2024-04-01 2025-10-09 Vitakey Inc. Heat-treated extended-release formulations

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507193A (en) 1949-05-17 1950-05-09 Bristol Lab Inc Penicillin product
US2882203A (en) 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
US2741573A (en) 1953-12-28 1956-04-10 Abbott Lab Penicillin compositions for intramuscular injection
US3676557A (en) 1971-03-02 1972-07-11 Endo Lab Long-acting narcotic antagonist formulations
JPS5416979B2 (de) 1972-01-08 1979-06-26
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4400391A (en) * 1980-01-09 1983-08-23 The United States Of America As Represented By The Secretary Of Agriculture Controlled release of bioactive materials using alginate gel beads
US4789516A (en) 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4690682A (en) 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4695463A (en) 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
JPH04502768A (ja) 1989-01-26 1992-05-21 アボット　バイオテク，インコーポレイテッド 疎水性蛋白質水溶液の安定化及び持続的放出ビヒクル
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5175093A (en) * 1989-11-07 1992-12-29 Lehigh University Bioactive cells immobilized in alginate beads containing voids formed with polyethylene glycol
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
EP0610441A4 (de) * 1991-10-29 1996-01-10 Clover Cons Ltd Vernetzbare polysacchariden, polykationen und lipiden verwendbar zum einkapseln und abgabe von arzneimitteln.
US5656297A (en) 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5711968A (en) 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5451411A (en) * 1993-10-15 1995-09-19 University Of Washington Methods and compositions for the oral delivery of therapeutic agents
JPH10503179A (ja) 1994-06-24 1998-03-24 イミュネックス・コーポレーション 放出制御性ポリペプチド組成物および炎症性腸疾患の治療方法
US5629184A (en) 1995-01-25 1997-05-13 Amgen Inc. Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
AU6242096A (en) 1995-06-27 1997-01-30 Takeda Chemical Industries Ltd. Method of producing sustained-release preparation
EP0877627A1 (de) 1996-01-25 1998-11-18 Eli Lilly And Company Analoge verbindungen des obesitätsproteins und ihre zubereitungen
AU1838797A (en) 1996-02-06 1997-08-28 Eli Lilly And Company Obesity protein compounds and formulations thereof

Also Published As

Publication number Publication date
US20020001619A1 (en) 2002-01-03
AU6973498A (en) 1998-11-11
DK0975333T3 (da) 2007-06-18
ZA983089B (en) 1998-10-19
EP0975333B1 (de) 2007-02-21
DE69837140D1 (de) 2007-04-05
EP0975333A1 (de) 2000-02-02
ES2283052T3 (es) 2007-10-16
WO1998046211A1 (en) 1998-10-22
JP2001524084A (ja) 2001-11-27
US6656508B2 (en) 2003-12-02
TW577755B (en) 2004-03-01
DE69837140T2 (de) 2007-11-29
PT975333E (pt) 2007-05-31
CA2286092C (en) 2004-12-14
CA2286092A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
ATE354351T1 (de) Alginatgele mit verzögerter freisetzung
ATE343378T1 (de) Biologisch abbaubares alginatgel mit verzögerter freisetzung
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
DE69326809D1 (de) Alginatgel
BR9610156A (pt) Composição em gel
DE69524620D1 (de) Alginatgele
NO902386D0 (no) Alginatgeler.
ID30075A (id) Partikel gel superserap multikomponen
DE69826840D1 (de) Beleuchtungssystem
DE69507456D1 (de) Linsenraster verwendendes beleuchtungssystem
CY2005011I1 (el) ΑΝΘΡΩΠΙΝΑ ΑΝΤΙΣΩΜΑΤΑ ΤΑ ΟΠΟΙΑ ΔΕΣΜΕΥΟΥΝ ΤΟΝ ΑΝΘΡΩΠΙΝΟ TNFα
FI973198L (fi) Silloitetut indolit matriisimetalloproteaasi-inhibiittoreina
NO963748D0 (no) Brannslukningssystem
DE69601182D1 (de) Silicongelzusammensetzung
FI98495B (fi) Palonsammutuslaitteisto
DE19880705T1 (de) Bremssystem
KR970033836U (ko) 차량용 소화기 고정장치
KR970042768U (ko) 터보 차저를 이용한 브레이크 냉각장치
DE69718300D1 (de) Gel-dichtung
BR9503177A (pt) Gel dental
KR970056576U (ko) 신발에 반사물 붙임
KR970052335U (ko) 스튜디오용 조명등의 신축식 현가장치
KR970048678U (ko) 경운기용 브레이크장치
BR7502129U (pt) Praticável de base anatômica
ITAN950033A0 (it) Ferro da cavallo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975333

Country of ref document: EP

REN Ceased due to non-payment of the annual fee